Source: World Journal of Urology. Unidade: FMRP
Subjects: SÍNDROME X METABÓLICA, NEOPLASIAS PROSTÁTICAS, ANTINEOPLÁSICOS, HORMÔNIO LIBERADOR DE GONADOTROFINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VARGAS, Andreza et al. LHRH analog therapy is associated with worse metabolic side effects than bilateral orchiectomy in prostate cancer. World Journal of Urology, v. 34, n. 12, p. 1621-1628, 2016Tradução . . Disponível em: https://doi.org/10.1007/s00345-016-1831-5. Acesso em: 02 nov. 2024.APA
Vargas, A., Machado, R. D., Ianni Filho, M., Paiva, C. E., Reis, R. B. dos, Tobias-Machado, M., & Faria, E. F. (2016). LHRH analog therapy is associated with worse metabolic side effects than bilateral orchiectomy in prostate cancer. World Journal of Urology, 34( 12), 1621-1628. doi:10.1007/s00345-016-1831-5NLM
Vargas A, Machado RD, Ianni Filho M, Paiva CE, Reis RB dos, Tobias-Machado M, Faria EF. LHRH analog therapy is associated with worse metabolic side effects than bilateral orchiectomy in prostate cancer [Internet]. World Journal of Urology. 2016 ; 34( 12): 1621-1628.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1007/s00345-016-1831-5Vancouver
Vargas A, Machado RD, Ianni Filho M, Paiva CE, Reis RB dos, Tobias-Machado M, Faria EF. LHRH analog therapy is associated with worse metabolic side effects than bilateral orchiectomy in prostate cancer [Internet]. World Journal of Urology. 2016 ; 34( 12): 1621-1628.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1007/s00345-016-1831-5
